Castle biosciences to participate at the baird 2021 healthcare esg symposium

Friendswood, texas--(business wire)---- $cstl #bairdesgconference--castle biosciences, inc. (nasdaq: cstl), a dermatologic diagnostics company providing personalized genomic information to inform treatment decisions, today announced that derek maetzold, president and chief executive officer, is scheduled to present a company overview at the baird 2021 healthcare esg symposium on june 17, 2021, at 11:20 a.m. eastern time. a live audio webcast of the company's presentation will be available by visiting castle biosciences' web
CSTL Ratings Summary
CSTL Quant Ranking